Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Map3k4 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Map3k4 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of MAP3K4 mRNA | CTD | PMID:22206623 | Map3k4 | Rat | 17beta-estradiol | multiple interactions | ISO | MAP3K4 (Homo sapiens) | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of MAP3K4 mRNA; IGF1R mutant form promotes more ... | CTD | PMID:18692832|PMID:23094148 | Map3k4 | Rat | 17beta-estradiol | increases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | Estradiol results in increased expression of MAP3K4 mRNA | CTD | PMID:23094148 | Map3k4 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MAP3K4 protein | CTD | PMID:31675489 | Map3k4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Map3k4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MAP3K4 mRNA | CTD | PMID:19465110 | Map3k4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Map3k4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MAP3K4 mRNA | CTD | PMID:19770486|PMID:26290441 | Map3k4 | Rat | 2,4,6-tribromophenol | decreases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | 2,4,6-tribromophenol results in decreased expression of MAP3K4 mRNA | CTD | PMID:31675489 | Map3k4 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of MAP3K4 mRNA | CTD | PMID:21346803 | Map3k4 | Rat | 2-methylcholine | affects expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of MAP3K4 mRNA | CTD | PMID:21179406 | Map3k4 | Rat | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | tetrabromobisphenol A results in decreased expression of MAP3K4 protein | CTD | PMID:31675489 | Map3k4 | Rat | 4,4'-diaminodiphenylmethane | affects expression | ISO | Map3k4 (Mus musculus) | 6480464 | 4,4'-diaminodiphenylmethane affects the expression of MAP3K4 mRNA | CTD | PMID:18648102 | Map3k4 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Map3k4 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of MAP3K4 mRNA | CTD | PMID:24780913 | Map3k4 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of MAP3K4 mRNA | CTD | PMID:25825206 | Map3k4 | Rat | aldehydo-D-glucose | increases expression | ISO | Map3k4 (Mus musculus) | 6480464 | Glucose results in increased expression of MAP3K4 mRNA | CTD | PMID:24659233 | Map3k4 | Rat | aldehydo-D-glucose | multiple interactions | ISO | Map3k4 (Mus musculus) | 6480464 | resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K4 mRNA] | CTD | PMID:24659233 | Map3k4 | Rat | all-trans-retinoic acid | decreases expression | ISO | Map3k4 (Mus musculus) | 6480464 | Tretinoin results in decreased expression of MAP3K4 mRNA | CTD | PMID:16604517 | Map3k4 | Rat | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of MAP3K4 mRNA | CTD | PMID:30779732 | Map3k4 | Rat | aristolochic acid A | decreases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of MAP3K4 mRNA | CTD | PMID:33212167 | Map3k4 | Rat | arsane | affects methylation | ISO | MAP3K4 (Homo sapiens) | 6480464 | Arsenic affects the methylation of MAP3K4 gene | CTD | PMID:25304211 | Map3k4 | Rat | arsenic atom | affects methylation | ISO | MAP3K4 (Homo sapiens) | 6480464 | Arsenic affects the methylation of MAP3K4 gene | CTD | PMID:25304211 | Map3k4 | Rat | arsenite(3-) | increases expression | ISO | Map3k4 (Mus musculus) | 6480464 | arsenite results in increased expression of MAP3K4 mRNA | CTD | PMID:18191166 | Map3k4 | Rat | arsenite(3-) | multiple interactions | ISO | MAP3K4 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to MAP3K4 mRNA] | CTD | PMID:32406909 | Map3k4 | Rat | benzo[a]pyrene | decreases expression | ISO | Map3k4 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of MAP3K4 mRNA | CTD | PMID:19770486 | Map3k4 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MAP3K4 mRNA | CTD | PMID:25181051|PMID:30816183|PMID:32528016 | Map3k4 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Map3k4 | Rat | bisphenol A | decreases methylation | ISO | MAP3K4 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of MAP3K4 gene | CTD | PMID:31601247 | Map3k4 | Rat | bisphenol A | decreases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of MAP3K4 protein | CTD | PMID:31675489 | Map3k4 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of MAP3K4 gene | CTD | PMID:28505145 | Map3k4 | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Map3k4 | Rat | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of MAP3K4 mRNA | CTD | PMID:19167457 | Map3k4 | Rat | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of MAP3K4 mRNA | CTD | PMID:33453195 | Map3k4 | Rat | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of MAP3K4 mRNA | CTD | PMID:36928142 | Map3k4 | Rat | caffeine | affects phosphorylation | ISO | MAP3K4 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of MAP3K4 protein | CTD | PMID:35688186 | Map3k4 | Rat | carbon nanotube | multiple interactions | ISO | MAP3K4 (Homo sapiens) | 6480464 | [Nanotubes, Carbon co-treated with calfactant] results in decreased expression of MAP3K4 protein | CTD | PMID:23026733 | Map3k4 | Rat | carbon nanotube | decreases expression | ISO | Map3k4 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of MAP3K4 mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25554681|PMID:25620056 | Map3k4 | Rat | CGP 52608 | multiple interactions | ISO | MAP3K4 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MAP3K4 gene] | CTD | PMID:28238834 | Map3k4 | Rat | chlorpyrifos | decreases expression | ISO | Map3k4 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of MAP3K4 mRNA | CTD | PMID:37019170 | Map3k4 | Rat | cisplatin | multiple interactions | ISO | MAP3K4 (Homo sapiens) | 6480464 | [Cisplatin co-treated with Quercetin] results in increased expression of MAP3K4 mRNA | CTD | PMID:27514524 | Map3k4 | Rat | cisplatin | increases expression | ISO | Map3k4 (Mus musculus) | 6480464 | Cisplatin results in increased expression of MAP3K4 mRNA | CTD | PMID:21151649 | Map3k4 | Rat | copper atom | multiple interactions | ISO | MAP3K4 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of MAP3K4 mRNA | CTD | PMID:30911355 | Map3k4 | Rat | copper(0) | multiple interactions | ISO | MAP3K4 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of MAP3K4 mRNA | CTD | PMID:30911355 | Map3k4 | Rat | copper(II) sulfate | decreases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of MAP3K4 mRNA | CTD | PMID:19549813 | Map3k4 | Rat | cyclosporin A | decreases expression | ISO | Map3k4 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of MAP3K4 mRNA | CTD | PMID:19770486 | Map3k4 | Rat | cypermethrin | increases expression | EXP | | 6480464 | cypermethrin results in increased expression of MAP3K4 mRNA | CTD | PMID:22528246 | Map3k4 | Rat | D-glucose | increases expression | ISO | Map3k4 (Mus musculus) | 6480464 | Glucose results in increased expression of MAP3K4 mRNA | CTD | PMID:24659233 | Map3k4 | Rat | D-glucose | multiple interactions | ISO | Map3k4 (Mus musculus) | 6480464 | resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K4 mRNA] | CTD | PMID:24659233 | Map3k4 | Rat | decabromodiphenyl ether | decreases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | decabromobiphenyl ether results in decreased expression of MAP3K4 protein | CTD | PMID:31675489 | Map3k4 | Rat | dibutyl phthalate | decreases expression | ISO | Map3k4 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of MAP3K4 mRNA | CTD | PMID:21266533 | Map3k4 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of MAP3K4 mRNA | CTD | PMID:17379624 | Map3k4 | Rat | dorsomorphin | multiple interactions | ISO | MAP3K4 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Map3k4 | Rat | doxorubicin | increases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of MAP3K4 mRNA | CTD | PMID:29803840 | Map3k4 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of MAP3K4 mRNA | CTD | PMID:29391264 | Map3k4 | Rat | enzyme inhibitor | multiple interactions | ISO | MAP3K4 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation more ... | CTD | PMID:23301498 | Map3k4 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of MAP3K4 mRNA | CTD | PMID:24793618 | Map3k4 | Rat | formaldehyde | decreases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of MAP3K4 mRNA | CTD | PMID:20655997 | Map3k4 | Rat | FR900359 | increases phosphorylation | ISO | MAP3K4 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of MAP3K4 protein | CTD | PMID:37730182 | Map3k4 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of MAP3K4 mRNA | CTD | PMID:33387578 | Map3k4 | Rat | glucose | increases expression | ISO | Map3k4 (Mus musculus) | 6480464 | Glucose results in increased expression of MAP3K4 mRNA | CTD | PMID:24659233 | Map3k4 | Rat | glucose | multiple interactions | ISO | Map3k4 (Mus musculus) | 6480464 | resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K4 mRNA] | CTD | PMID:24659233 | Map3k4 | Rat | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of MAP3K4 gene | CTD | PMID:35440735 | Map3k4 | Rat | ivermectin | decreases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of MAP3K4 protein | CTD | PMID:32959892 | Map3k4 | Rat | josamycin | decreases response to substance | ISO | MAP3K4 (Homo sapiens) | 6480464 | MAP3K4 protein results in decreased susceptibility to Josamycin | CTD | PMID:31915244 | Map3k4 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of MAP3K4 mRNA | CTD | PMID:25234470 | Map3k4 | Rat | nitrates | multiple interactions | ISO | Map3k4 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MAP3K4 more ... | CTD | PMID:35964746 | Map3k4 | Rat | paracetamol | affects expression | ISO | Map3k4 (Mus musculus) | 6480464 | Acetaminophen affects the expression of MAP3K4 mRNA | CTD | PMID:17562736 | Map3k4 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MAP3K4 mRNA | CTD | PMID:33387578 | Map3k4 | Rat | phenytoin | increases expression | EXP | | 6480464 | Phenytoin results in increased expression of MAP3K4 mRNA | CTD | PMID:20345932 | Map3k4 | Rat | pirinixic acid | multiple interactions | ISO | Map3k4 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Map3k4 | Rat | progesterone | increases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | Progesterone results in increased expression of MAP3K4 mRNA | CTD | PMID:20864642 | Map3k4 | Rat | progesterone | multiple interactions | ISO | MAP3K4 (Homo sapiens) | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of MAP3K4 mRNA | CTD | PMID:18692832 | Map3k4 | Rat | propiconazole | decreases expression | ISO | Map3k4 (Mus musculus) | 6480464 | propiconazole results in decreased expression of MAP3K4 mRNA | CTD | PMID:21278054 | Map3k4 | Rat | quercetin | multiple interactions | ISO | MAP3K4 (Homo sapiens) | 6480464 | [Cisplatin co-treated with Quercetin] results in increased expression of MAP3K4 mRNA | CTD | PMID:27514524 | Map3k4 | Rat | quercetin | decreases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of MAP3K4 mRNA | CTD | PMID:21632981 | Map3k4 | Rat | resveratrol | multiple interactions | ISO | Map3k4 (Mus musculus) | 6480464 | resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K4 mRNA] | CTD | PMID:24659233 | Map3k4 | Rat | resveratrol | multiple interactions | ISO | MAP3K4 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of MAP3K4 mRNA | CTD | PMID:23557933 | Map3k4 | Rat | rotenone | decreases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of MAP3K4 protein | CTD | PMID:39603559 | Map3k4 | Rat | SB 431542 | multiple interactions | ISO | MAP3K4 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Map3k4 | Rat | serpentine asbestos | decreases methylation | ISO | MAP3K4 (Homo sapiens) | 6480464 | Asbestos, Serpentine results in decreased methylation of MAP3K4 promoter | CTD | PMID:29626692 | Map3k4 | Rat | sodium arsenate | decreases expression | ISO | Map3k4 (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of MAP3K4 mRNA | CTD | PMID:30953684 | Map3k4 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of MAP3K4 mRNA | CTD | PMID:31150632 | Map3k4 | Rat | tetrachloromethane | decreases expression | ISO | Map3k4 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of MAP3K4 mRNA | CTD | PMID:31919559 | Map3k4 | Rat | titanium dioxide | decreases methylation | ISO | Map3k4 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of MAP3K4 promoter | CTD | PMID:35295148 | Map3k4 | Rat | titanium dioxide | increases methylation | ISO | Map3k4 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of MAP3K4 gene | CTD | PMID:35295148 | Map3k4 | Rat | trichloroethene | multiple interactions | ISO | Map3k4 (Mus musculus) | 6480464 | PPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of MAP3K4 mRNA] | CTD | PMID:15363585 | Map3k4 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of MAP3K4 mRNA | CTD | PMID:33387578 | Map3k4 | Rat | trichostatin A | increases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of MAP3K4 mRNA | CTD | PMID:24935251|PMID:26272509 | Map3k4 | Rat | trichostatin A | multiple interactions | ISO | MAP3K4 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Map3k4 | Rat | triphenyl phosphate | affects expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of MAP3K4 mRNA | CTD | PMID:37042841 | Map3k4 | Rat | troglitazone | decreases expression | ISO | Map3k4 (Mus musculus) | 6480464 | troglitazone results in decreased expression of MAP3K4 mRNA | CTD | PMID:28973697 | Map3k4 | Rat | tungsten | decreases expression | ISO | Map3k4 (Mus musculus) | 6480464 | Tungsten results in decreased expression of MAP3K4 mRNA | CTD | PMID:30912803 | Map3k4 | Rat | valproic acid | decreases expression | ISO | Map3k4 (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of MAP3K4 mRNA | CTD | PMID:21427059 | Map3k4 | Rat | valproic acid | multiple interactions | ISO | MAP3K4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Map3k4 | Rat | valproic acid | increases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MAP3K4 mRNA | CTD | PMID:23179753|PMID:26272509|PMID:29154799 | Map3k4 | Rat | valproic acid | decreases methylation | ISO | MAP3K4 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of MAP3K4 gene | CTD | PMID:29154799 | Map3k4 | Rat | valproic acid | affects expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of MAP3K4 mRNA | CTD | PMID:25979313 | Map3k4 | Rat | valproic acid | decreases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of MAP3K4 mRNA | CTD | PMID:19101580 | Map3k4 | Rat | vanadium atom | decreases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | Vanadium results in decreased expression of MAP3K4 mRNA | CTD | PMID:19000753 | Map3k4 | Rat | vanadium(0) | decreases expression | ISO | MAP3K4 (Homo sapiens) | 6480464 | Vanadium results in decreased expression of MAP3K4 mRNA | CTD | PMID:19000753 | |






















